Omios Biologics
PrivateLast Round
Pre Seed
Oct 1, 2025
Company Overview
Omios Biologics operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a Pre Seed round in October 2025.
Omios Biologics is a biotechnology company developing next-generation oncolytic virus immunotherapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omios Biologics Comparables
Compare Omios Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VacV Biotherapeutics | 84% | |
| SillaJen Inc | 77% | |
| Vyriad | 76% |
For institutional investors. Book with your work email.
Omios Biologics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Omios Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FuturePlay | Pre Seed |
| NYU Innovation Venture Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Led by FuturePlay and NYU Langone Health Venture Fund.
For institutional investors. Book with your work email.
Omios Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omios Biologics's valuation, stock price, and market status.
Is Omios Biologics a public or private company?
Omios Biologics is a private company.
What is the current stock price of Omios Biologics?
Omios Biologics is a private company, so its shares have no public market price. Caplight tracks Omios Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omios Biologics worth (valuation)?
Valuation information for Omios Biologics is not publicly available.
Can I buy Omios Biologics stock?
Omios Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omios Biologics's last funding round?
Omios Biologics's most recent funding round was Pre Seed on October 1, 2025.
Who are the main investors in Omios Biologics?
Key investors in Omios Biologics include FuturePlay.
Will Omios Biologics IPO soon?
No public IPO plans have been announced for Omios Biologics.
How can I track Omios Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Omios Biologics's shares on secondary markets.